The global Artificial Intelligence Market Analysis is projected to be valued at USD 279.22 billion in 2024 and reach USD 1,811.75 billion by 2030, growing at a CAGR of 36.6% according to a new report ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

Capricor's lead asset, deramiocel, targets DMD-related cardiomyopathy and faces key FDA milestones. Find out why CAPR stock ...